PMID: 23922468
In spite of that, my results came within the expected timeframe, with visible brightening around weeks 3-4 that kept improving
What makes BPC-157 so unique is that it doesnt override the bodys systems it supports and enhances them, allowing for faster, more complete recovery without the suppression, rebound, or systemic disruption associated with other compounds
Commercial context: author holds copper-peptide intellectual property
Samples that were the most responsive to ascites treatment were subsequently made into MOS and treated with the following conditions: DMSO control, 20% ascites, IKE (50 M), IKE (50 M) and 20% ascites, bezafibrate (1 mM), bezafibrate (1 mM) and 20% ascites, bezafibrate (1 mM) and IKE (50 M), and bezafibrate (1 mM) and IKE (50 M) and 20% ascites
In addition, we investigated changes in brain metabolism through in vivo quantitative MRS in the PFC and Hip (WKY/CMS: n = 8